Clinical Trial Update: Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating the immune effects of vedolizumab with or without anti-TNF pre-treatment in Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: COMPLETED